| A draft map of the human proteome MS Kim, SM Pinto, D Getnet, RS Nirujogi, SS Manda, R Chaerkady, ... Nature 509 (7502), 575-581, 2014 | 2433 | 2014 |
| Activation of diverse signalling pathways by oncogenic PIK3CA mutations X Wu, S Renuse, NA Sahasrabuddhe, MS Zahari, R Chaerkady, MS Kim, ... Nature communications 5 (1), 4961, 2014 | 75 | 2014 |
| Global phosphotyrosine survey in triple-negative breast cancer reveals activation of multiple tyrosine kinase signaling pathways X Wu, MS Zahari, B Ma, R Liu, S Renuse, NA Sahasrabuddhe, L Chen, ... Oncotarget 6 (30), 29143, 2015 | 57 | 2015 |
| The non-receptor tyrosine kinase TNK2/ACK1 is a novel therapeutic target in triple negative breast cancer X Wu, MZ Saddiq, S Renuse, DS Kelkar, MA Barbhuiya, PL Rojas, ... Oncotarget 8 (2), 2971, 2017 | 38 | 2017 |
| Phosphoproteomic analysis identifies focal adhesion kinase 2 (FAK2) as a potential therapeutic target for tamoxifen resistance in breast cancer X Wu, MS Zahari, S Renuse, RS Nirujogi, MS Kim, SS Manda, V Stearns, ... Molecular & Cellular Proteomics 14 (11), 2887-2900, 2015 | 34 | 2015 |
| Quantitative phosphoproteomic analysis reveals reciprocal activation of receptor tyrosine kinases between cancer epithelial cells and stromal fibroblasts X Wu, MS Zahari, S Renuse, NA Sahasrabuddhe, R Chaerkady, MS Kim, ... Clinical proteomics 15, 1-14, 2018 | 19 | 2018 |
| Phosphoproteomic profiling of tumor tissues identifies HSP27 Ser82 phosphorylation as a robust marker of early ischemia MS Zahari, X Wu, SM Pinto, RS Nirujogi, MS Kim, B Fetics, M Philip, ... Scientific reports 5 (1), 13660, 2015 | 17 | 2015 |
| A phosphoproteomic screen demonstrates differential dependence on HER3 for MAP kinase pathway activation by distinct PIK3CA mutations BG Blair, X Wu, MS Zahari, M Mohseni, J Cidado, HY Wong, JA Beaver, ... Proteomics 15 (2-3), 318-326, 2015 | 15 | 2015 |
| A breast cancer cell microarray (CMA) as a rapid method to characterize candidate biomarkers X Wu, MS Zahari, S Renuse, HKC Jacob, S Sakamuri, M Singal, ... Cancer Biology & Therapy 15 (12), 1593-1599, 2014 | 14 | 2014 |
| Activating Mutations in PIK3CA Lead to Widespread Modulation of the Tyrosine Phosphoproteome MS Zahari, X Wu, BG Blair, SM Pinto, RS Nirujogi, CA Jelinek, R Malhotra, ... Journal of proteome research 14 (9), 3882-3891, 2015 | 13 | 2015 |
| Targeted phosphoproteomics of the Ras signaling network reveal regulatory mechanisms mediated by oncogenic KRAS A Urisman, TL Yuan, M Trinidad, JH Morris, S Afghani, JA Oses-Prieto, ... bioRxiv, 695460, 2019 | 2 | 2019 |
| Phosphoproteomic analysis identifies FAK2 as a potential therapeutic target for tamoxifen resistance in breast cancer X Wu, MS Zahari, S Renuse, RS Nirujogi, MS Kim, SS Manda, V Stearns, ... Mol. Cell. Proteom., 2015 | 1 | 2015 |
| Correction to: Quantitative phosphoproteomic analysis reveals reciprocal activation of receptor tyrosine kinases between cancer epithelial cells and stromal fibroblasts. X Wu, MS Zahari, S Renuse, NA Sahasrabuddhe, R Chaerkady, MS Kim, ... Clinical proteomics 15 (1), 37, 2018 | | 2018 |
| Global Analysis of the PI3K Signaling Pathway MS Zahari The Johns Hopkins University, 2016 | | 2016 |
